论文信息 - Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study - 字舞流文

Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study

J. Sancho | M. Hutchings | P. Langmuir | M. Coleman | M. Hamadani | R. Boccia | Hui-qiong Liu | J. Ďuraš | M. Stouffs | M. B. Oreiro | P. Zinzani | R. Córdoba | V. Williams